Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Title
Regulating Pharmaceutical Prices in India : Policy Design, Implementation and Compliance / by Ajay Bhaskarabhatla.
ISBN
9783319933931 (electronic book)
3319933930 (electronic book)
9783319933924
3319933922
Published
Cham : Springer International Publishing : Imprint : Springer, 2018.
Language
English
Description
1 online resource (ix, 306 pages) : illustrations.
Item Number
10.1007/978-3-319-93393-1 doi
Call Number
RA410-410.9
Dewey Decimal Classification
338.473621
Summary
This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India's 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Series
India studies in business and economics.
Available in Other Form
Print version: 9783319933924
Introduction
Part I. Historical Context and the Motivation for Regulation
Brief History of Regulating Pharmaceutical Prices
Is the 2013 Price Control Regulation Necessary?
Part II. The Design of the 2013 DPCO Regulation
The Proposed Design to Fix Ceiling Prices Under 2013 DPCO
Challenges with Fixing the Ceiling Price Under the 2013 DPCO
Part III. The Impact of the 2013 DPCO
How Effective Are the 2013 DPCO Regulations?
Firm Strategies to Mitigate the Impact of Price Control Regulation
Part IV. Enforcement and Compliance
Enforcement and Compliance with Price Ceilings on Essential Medicines
Conclusion.